Viatris to Participate in UBS and Jefferies Healthcare Conferences.

Viatris Inc., a global healthcare company, will participate in two upcoming healthcare conferences in November 2025. The company will participate in a fireside chat at the UBS Global Healthcare Conference 2025 on November 11 and at the Jefferies Global Healthcare Conference in London on November 18. Investors and the general public can listen to the sessions live at investor.viatris.com or access archived versions later.

Viatris Inc. (Nasdaq: VTRS), a leading global healthcare company, has announced its participation in two significant healthcare conferences in November 2025. The company will engage in fireside chats at both the UBS Global Healthcare Conference 2025 and the Jefferies Global Healthcare Conference in London. These events provide an opportunity for investors and the general public to gain insights into Viatris' strategic vision and recent developments.

The UBS Global Healthcare Conference 2025 will take place on November 11, 2025, at 8:45 a.m. ET, where Viatris will participate in a fireside chat. The company will also take part in a fireside chat at the Jefferies Global Healthcare Conference in London on November 18, 2025, at 11:30 a.m. GMT / 6:30 a.m. ET. Both sessions will be accessible live at investor.viatris.com, with archived versions available for a limited time following the events Viatris to Participate in Upcoming Investor Conferences^[1]Viatris to Participate in Upcoming Investor Conferences^[2]Viatris to Participate in Upcoming Investor Conferences^[3].

Viatris Inc. is uniquely positioned to bridge the gap between generics and branded medicines, offering a comprehensive approach to global healthcare needs. With a mission to empower people worldwide to live healthier at every stage of life, Viatris provides access to high-quality medicines for approximately 1 billion patients annually Viatris to Participate in Upcoming Investor Conferences^[1]Viatris to Participate in Upcoming Investor Conferences^[2]Viatris to Participate in Upcoming Investor Conferences^[3].

The company's extensive portfolio of medicines, coupled with a robust global supply chain, allows it to reach more people when and where they need them. Viatris is headquartered in the U.S. with global centers in Pittsburgh, Shanghai, and Hyderabad, India Viatris to Participate in Upcoming Investor Conferences^[1]Viatris to Participate in Upcoming Investor Conferences^[2]Viatris to Participate in Upcoming Investor Conferences^[3].

Investors and the public are encouraged to tune in to these sessions to gain valuable insights into Viatris' strategic initiatives and future plans.